TrialBMJ open2021

CopenFast trial: Faster-acting insulin Fiasp versus insulin NovoRapid in the treatment of women with type 1 or type 2 diabetes during pregnancy and lactation - a randomised controlled trial.

Sidse Kjærhus Nørgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.